Literature DB >> 24337858

LC-MS/MS method for determination of megestrol in human plasma and its application in bioequivalence study.

Fan Li1, Xiao-Juan Zou1, Heng Zheng2, Yi Xiang3.   

Abstract

A rapid and highly selective liquid chromatography-tandem mass spectrometric (LC-MS/MS) method for the determination of megestrol in human plasma was described using medrysone as internal standard (IS). Blood samples were collected from 20 healthy volunteers after oral administration of 160 mg megestrol acetate dispersible tablets. The analytes were extracted by liquid-liquid extraction procedure and separated on a hanbon lichrospher column with the mobile phase of methanol and water containing 0.1% formic acid and 20 mmol/L ammonium acetate (5:1, v/v). Positive ion electrospray ionization with multiple reaction-monitoring mode (MRM) was employed by monitoring the transitions m/z 385.5-325.4 and m/z 387.5-327.4 for megestrol and medrysone, respectively. Under the isocratic separation conditions, the chromatographic run time was approximately 2.54 min for megestrol and 2.59 min for medrysone. The calibration curve range was from 0.5 to 200.0 ng/mL. The inter-batch and intra-batch precision and accuracy were less than 5.2% relative standard deviation (RSD) and 6.4% relative error (RE). The proposed method was successfully applied in the bioequivalence study of megestrol acetate dispersible tablets.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24337858     DOI: 10.1007/s11596-013-1221-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  15 in total

1.  Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial.

Authors:  F De Conno; C Martini; E Zecca; A Balzarini; P Venturino; L Groff; A Caraceni
Journal:  Eur J Cancer       Date:  1998-10       Impact factor: 9.162

2.  Effect of megestrol acetate and prepulsid on nutritional improvement in patients with head and neck cancers undergoing radiotherapy.

Authors:  H C Chen; S W Leung; C J Wang; L M Sun; F M Fang; J H Hsu
Journal:  Radiother Oncol       Date:  1997-04       Impact factor: 6.280

3.  Oral metronomic chemo-hormonal-therapy of metastatic breast cancer with cyclophosphamide and megestrol acetate.

Authors:  A Licchetta; P Correale; C Migali; C Remondo; E Francini; A Pascucci; A Magliocca; A Guarnieri; V Savelli; A Piccolomini; A F Carli; G Francini
Journal:  J Chemother       Date:  2010-06       Impact factor: 1.714

4.  Plasma concentrations of megestrol acetate and medroxyprogesterone acetate after single oral administration to healthy subjects.

Authors:  H Adlercreutz; P B Eriksen; M S Christensen
Journal:  J Pharm Biomed Anal       Date:  1983       Impact factor: 3.935

5.  A randomised phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancer.

Authors:  N S Stuart; J Warwick; G R Blackledge; D Spooner; C Keen; A R Taylor; C Tyrell; D J Webster; H Earl
Journal:  Eur J Cancer       Date:  1996-10       Impact factor: 9.162

6.  Supportive use of megestrol acetate in patients with head and neck cancer during radio(chemo)therapy.

Authors:  R Fietkau; M Riepl; H Kettner; A Hinke; R Sauer
Journal:  Eur J Cancer       Date:  1997-01       Impact factor: 9.162

7.  A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer.

Authors:  W Jonat; A Howell; C Blomqvist; W Eiermann; G Winblad; C Tyrrell; L Mauriac; H Roche; S Lundgren; R Hellmund; M Azab
Journal:  Eur J Cancer       Date:  1996-03       Impact factor: 9.162

Review 8.  Results of curettage for postmenopausal vaginal bleeding in women treated with tamoxifen and megestrol acetate for progressive metastatic breast carcinoma.

Authors:  A Logmans; H V Mous; M Bontenbal; H Beerman; M van Lent
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1994-09       Impact factor: 2.435

9.  Safety of megestrol acetate in palliating anorexia-cachexia syndrome in patients with castration-resistant prostate cancer.

Authors:  Sungwoo Hong; In Gab Jeong; Dalsan You; Jae-Lyun Lee; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  J Korean Med Sci       Date:  2013-05-02       Impact factor: 2.153

10.  Simultaneous determination of hormonal residues in treated waters using ultrahigh performance liquid chromatography-tandem mass spectrometry.

Authors:  Rayco Guedes-Alonso; Zoraida Sosa-Ferrera; José Juan Santana-Rodríguez
Journal:  J Anal Methods Chem       Date:  2013-03-06       Impact factor: 2.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.